Table 1.

Clinical data of 18 patients participating in the study.

Patient	Age (y)	PSA level (ng/mL)	Prostate volume (cc)	Lesion characteristics				Pathologic tumor stage
				Size (cc)	Gleason grade	Location	Total number of ROIs per lesion (from different slices)
P01	65	13.1	32.3	5.8	4+3	PZ	7	pT3a
P02	65	4.6	67.5	0.1	3+4	TZ	1	pT2c
				0.1	3+3	TZ	1
				2×0.1	3+3	PZ	2
P03	67	8	94.7	0.7	3+3	PZ	4	pT2c
				2×0.2	3+3	PZ	4
				0.5	3+3	TZ	2
				0.3	3+3	TZ	3
P04	62	6.5	31.0	3.2	4+3	PZ	6	pT3a
				0.2	4+3	PZ	2
				0.1	3+3	PZ	1
				0.5	3+3	TZ	4
P05	80	7.2	128.3	0.1	3+3	PZ	2	pT2a
P06	64	7.6	32.3	7.5	4+3	PZ	8	pT3a
				0.9	3+3	PZ	4
P07	75	18.2	41.1	3.3	4+3	PZ	5	pT2c
				1.5	3+3	PZ	4
				3×0.1	3+3	PZ	3
				4×0.1	3+3	TZ	4
				5×0.2	3+3	TZ	9
P08	62	13.5	23.4	6.8	4+5	PZ	8	pT3b
				0.3	3+3	PZ	2
				3×0.1	3+3	PZ	3
P09	75	7.9	31.0	0.9	4+5	PZ	2	pT3a
				0.5	4+3	PZ	1
				0.3	3+3	TZ	2
P10	69	18.4	39.5	6.2	4+5	TZ	5	pT3a
P11	66	7.4	32.5	1.0	3+4	PZ	1	pT3a
P12	67	6	17.7	1.3	3+4	PZ	3	pT3a
				0.1	3+3	PZ	1
				0.6	3+3	TZ	2
P13	58	6.7	31.4	6.1	3+4	PZ	8	pT3a
				3.3	3+4	PZ	5
P14	58	12	20.2	3.9	3+4	PZ	5	pT3a
				0.1	3+3	PZ	1
				0.2	3+3	TZ	1
P15	66	31.6	44.9	6.6	4+3	PZ	9	pT3a
P16	75	8.5	36.6	3.2	4+5	PZ	4	pT3a
				0.4	4+5	PZ	2
				0.1	3+3	PZ	1
P17	63	51	26.4	9.5	4+5	PZ	6	pT3b
P18	62	13.3	33.3	2.1	4+4	PZ	4	pT3a